RankingsPricing
  1. US-listed companies
  2. QIAGEN N.V.
  3. Financials
  4. Capital expenditures

QIAGEN N.V.QGEN

Market cap
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-167+11.67%
Dec 31, 2023-150+15.85%
Dec 31, 2022-129-31.95%
Dec 31, 2021-190+43.01%
Dec 31, 2020-133+12.58%
Dec 31, 2019-118+7.45%
Dec 31, 2018-110+21.86%
Dec 31, 2017-90+20.86%
Dec 31, 2016-75-23.77%
Dec 31, 2015-98+12.92%
Dec 31, 2014-87+2.51%
Dec 31, 2013-84-17.18%
Dec 31, 2012-102+17.50%
Dec 31, 2011-87+8.96%
Dec 31, 2010-80

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)